Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Cancer

• Publication date

  1996-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5PMID 8608507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The significance of inflammation and regression in melanoma

  2006cited by this paper
• Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer.

  1992cited by this paper
• Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors

  1991cited by this paper
• Patterns of human tumor-infiltrating lymphocytes in 120 human cancers.

  1990cited by this paper
• Model predicting survival in stage I melanoma based on tumor progression.

  1989cited by this paper
• The biologic forms of malignant melanoma.

  1986cited by this paper
• The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51—3.99 mm)

  1985cited by this paper
• Stage I melanoma of the skin: Evaluation of prognosis according to histologic characteristics

  1981cited by this paper
• Prognostic index in malignant melanoma.

  1978cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

  1977cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

  1976cited by this paper
• Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma

  1970cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• GLUT1 expression, lymphocyte distribution and CD3+ T-cell metabolic subsets as predictive markers of response to immunotherapy in advanced melanoma

  2026cites this paper
• From Immunobiology to Clinical Application: Tumor-Infiltrating Lymphocytes in Melanoma

  2026cites this paper
• Transcriptomic signatures in peripheral CD4+T-lymphocytes may reflect melanoma staging and immunotherapy responsiveness prior to ICI initiation

  2025cites this paper
• Tumors and their microenvironments: Learning from pediatric brain pathologies

  2025cites this paper
• White Depressed Areas and Tumor Infiltrating Lymphocytes: The Cancer Cure That Lies Within?

  2025cites this paper
• Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach

  2025influential citation
• Case report: Low-dose radiation reverses pembrolizumab resistance in melanoma

  2025cites this paper
• CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success

  2025cites this paper
• Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade.

  2025cites this paper
• Tumor-Infiltrating Lymphocyte Therapy for the Treatment of Metastatic Melanoma

  2025cites this paper
• Human Immunodeficiency Virus-Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers.

  2025cites this paper
• The tumor immune microenvironment in primary cutaneous melanoma

  2025cites this paper
• Tumor-infiltrating lymphocytes in melanoma: diagnostic and prognostic implications from biopsy to circulation

  2025cites this paper
• Leveraging T cells for cancer immunotherapy

  2025cites this paper
• Targeting LAG3 to alter the tumor immune reactivity of CD8+T cells is a potential therapy for skin cutaneous melanoma

  2025cites this paper
• IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control

  2025cites this paper
• Tumor infiltrating lymphocytes in primary melanoma are associated with a better prognosis.

  2025cites this paper
• Impact of melanoma histological regression on first-line immunotherapy response in stage-IV disease.

  2025cites this paper
• Evaluation of Tumor‐Infiltrating Leukocytes in Endolymphatic Sac Tumor

  2025cites this paper
• TCR-based cellular immunotherapy for hepatocellular carcinoma: advances, challenges, and prospects

  2025cites this paper
• Single-domain antibodies targeting the pan-T-cell markers CD2 and CD7 as universal immunotherapy T-cell tracers

  2025cites this paper
• Prognostic Value of Neutrophil-Lymphocyte Ratio Change After Short-Term Chemotherapy in De Novo Stage IV Breast Cancer Patients

  2025cites this paper
• Tumor infiltrating lymphocytes (TILs) - Pathologia, quo vadis? - A global survey.

  2024cites this paper
• A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer

  2024cites this paper
• Downregulation of MHC-I on melanoma cells and decreased CD8+ T-cell infiltration are associated with metastatic spread and resistance to immunotherapy.

  2024cites this paper
• A machine learning model reveals expansive downregulation of ligand-receptor interactions that enhance lymphocyte infiltration in melanoma with developed resistance to immune checkpoint blockade

  2024cites this paper
• The Role of Lymphocytic Infiltrates in the Tumor Microenvironment as a Predictive Factor for the Response to Immunotherapy in Solid Tumors: A Single-Center Experience From Romania

  2024cites this paper
• Distinct Transcriptomic and Tumor Microenvironment Profiles in Sinonasal Mucosal Melanoma and Aggressive Cutaneous Melanomas

  2024cites this paper
• Hypoxic transcriptomes predict survival and tumor-infiltrating immune cell composition in cutaneous melanoma

  2024cites this paper
• Density of high endothelial venules and PDL-1 expression: relationship with tumor-infiltrating lymphocytes in primary cutaneous melanomas.

  2024cites this paper
• Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma.

  2024cites this paper
• The prognostic value of tumor-infiltrating lymphocytes in vulvovaginal melanoma

  2024cites this paper
• Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy

  2024cites this paper
• Tumor-infiltrating lymphocytes in melanoma: from prognostic assessment to therapeutic applications

  2024cites this paper
• A Nomogram Based on Platelet Distribution Width-to-Lymphocyte Ratio to Predict Overall Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma

  2024cites this paper
• Prognostic value of tumour-associated regulatory T-cells as a biomarker in non-small cell lung cancer: a systematic review and meta-analysis

  2024cites this paper
• The Importance of Predictive Biomarkers and Their Correlation with the Response to Immunotherapy in Solid Tumors—Impact on Clinical Practice

  2024cites this paper
• Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients.

  2024cites this paper
• Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy

  2024cites this paper
• Immune checkpoint inhibitors in metastatic melanoma therapy (Review)

  2024cites this paper
• Role of tumor-infiltrating lymphocytes in melanoma prognosis and treatment strategies: A systematic review and meta-analysis

  2024influential citation
• Decoding the molecular landscape: A novel prognostic signature for uveal melanoma unveiled through programmed cell death-associated genes

  2024cites this paper
• Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis

  2024cites this paper
• Standardized Protocols for Clinical and Histopathological Characterization of Hidradenitis Suppurativa Tissue Specimens.

  2024cites this paper
• The combination of single-cell and RNA sequencing analysis decodes the melanoma tumor microenvironment and identifies novel T cell-associated signature genes

  2024cites this paper
• Retrospective study of a novel hematological parameter for predicting the survival of patients with nasopharyngeal carcinoma

  2024cites this paper
• Cancer Type and Histology Influence Cutaneous Immunotherapy Toxicities: A Multi-Institutional Cohort Study.

  2024cites this paper
• Comprehensive single-cell and bulk RNA-seq analyses reveal a novel CD8+ T cell-associated prognostic signature in ovarian cancer

  2024cites this paper
• Craters on the melanoma surface facilitate tumor-immune interactions and demonstrate pathologic response to checkpoint blockade in humans

  2024cites this paper
• Medullary Thyroid Cancer: Molecular Drivers and Immune Cellular Milieu of the Tumour Microenvironment—Implications for Systemic Treatment

  2024cites this paper
• Biophysical Control of the Glioblastoma Immunosuppressive Microenvironment: Opportunities for Immunotherapy

  2024cites this paper
• Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer

  2024cites this paper
• Immunosurveillance encounters cancer metabolism

  2024cites this paper
• Tumor-infiltrating lymphocytes as a prognostic and predictive factor for Melanoma

  2024cites this paper
• Dense tumor‐infiltrating lymphocytes (TILs) in liver metastasis from colorectal cancer are related to improved overall survival

  2024cites this paper
• The Genetic and Immunologic Landscape Underlying the Risk of Malignant Progression in Laryngeal Dysplasia

  2023cites this paper
• Infiltrado inflamatório tumoral não prediz metástases em melanomas cutâneos primários finos

  2023cites this paper
• Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay

  2023cites this paper
• Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.

  2023cites this paper
• Canine melanoma: A review of diagnostics and comparative mechanisms of disease and immunotolerance in the era of the immunotherapies

  2023cites this paper
• Predicting melanoma survival and metastasis with interpretable histopathological features and machine learning models

  2023cites this paper
• Spatial Proximity and Relative Distribution of Tumor-Infiltrating Lymphocytes and Macrophages Predict Survival in Melanoma.

  2023cites this paper
• An update on methods for detection of prognostic and predictive biomarkers in melanoma

  2023cites this paper
• Drug-microbiota interactions: an emerging priority for precision medicine

  2023cites this paper
• Immune microenvironment of cervical cancer and the role of IL-2 in tumor promotion.

  2023cites this paper
• Simple and easily accessible prognostic markers in ewing sarcoma; neutrophil-lymphocyte ratio, neutrophil-platelet score and systemic-inflammation index

  2023cites this paper
• Nonclassical monocytes potentiate anti-tumoral CD8+ T cell responses in the lungs

  2023cites this paper
• β2‐adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma

  2023cites this paper
• Deactivation of ligand-receptor interactions enhancing lymphocyte infiltration drives melanoma resistance to Immune Checkpoint Blockade

  2023cites this paper
• Tumor infiltrating lymphocytes recognition in primary melanoma by deep learning convolutional neural network.

  2023cites this paper
• Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastases

  2023cites this paper
• The Genomic Landscape of Melanoma and Its Therapeutic Implications

  2023cites this paper
• Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response.

  2023cites this paper
• Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1high with CD8/PD-1high

  2023cites this paper
• Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy.

  2023cites this paper
• Could immunoscore improve the prognostic and therapeutic management in patients with solid tumors?

  2023cites this paper
• Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?

  2022cites this paper
• Membrane Applications in Autologous Cell Therapy

  2022cites this paper
• Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management

  2022influential citation
• The clinicopathological significance and relapse predictive role of tumor microenvironment of intrahepatic cholangiocarcinoma after radical surgery

  2022cites this paper
• Comparative Evaluation of Tumor-Infiltrating Lymphocytes in Companion Animals: Immuno-Oncology as a Relevant Translational Model for Cancer Therapy

  2022cites this paper
• Microfluidics guided by deep learning for cancer immunotherapy screening

  2022cites this paper
• HLA-DRB1: A new potential prognostic factor and therapeutic target of cutaneous melanoma and an indicator of tumor microenvironment remodeling

  2022cites this paper
• ncRNA-Regulated LAYN Serves as a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Hepatocellular Carcinoma: A Bioinformatics Analysis

  2022cites this paper
• Combined Evaluation of mRNA and Protein Expression, Promoter Methylation, and Immune Infiltration of UBE2I in Pan-Digestive System Tumors

  2022cites this paper
• Towards Novel Gene and Cell Therapy Approaches for Cervical Cancer

  2022cites this paper
• Cancer immunoediting hypothesis: history, clinical implications and controversies

  2022cites this paper
• Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero?

  2022cites this paper
• Melanoma: An immunotherapy journey from bench to bedside.

  2022cites this paper
• Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome

  2022cites this paper
• Olfactory Receptor OR2H1 is an effective target for CAR T cells in human epithelial tumors.

  2022cites this paper
• Tumor Lymphocyte Infiltration Is Correlated with a Favorable Tumor Regression Grade after Neoadjuvant Treatment for Esophageal Adenocarcinoma

  2022cites this paper
• Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression

  2022cites this paper
• Depleting Ly6G Positive Myeloid Cells Reduces Pancreatic Cancer-Induced Skeletal Muscle Atrophy

  2022cites this paper
• Kanser ve İ mmün Sistem: Sistematik Derleme Cancer and Immune System: Systemat i c Rev i ew

  2022cites this paper
• Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions

  2022cites this paper
• Protein Expression of immune checkpoints STING and MHCII in small cell lung cancer

  2022influential citation
• Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers

  2022cites this paper
• Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysis.

  2022cites this paper
• Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort

  2022cites this paper